We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
Revvity Htrf Human Total Egfr Ex19del Detection Kit, 10,000 Assay Points
Revvity Drug Resistance In Patients With Egfr Mutated Non-Small Cell Lung Cancer Treated With Tyrosine Kinase Inhibitors (Tkis) Is One Of The Main Challenges For Targeted Cancer Therapy. - PEGSK (Additional S&H Or Hazmat Fees May Apply)
List Price
$13,739.00
Your Price
$13,739.00
HOW MUCH YOU SAVE:
0.00 %
| NETA PART: | PEGSK-64EGFRD19PEH |
| MFG.PART: | 64EGFRD19PEH |
| UNSPSC: | 41122102 |
| Manufacturer: | Revvity |
Revvity Drug resistance in patients with egfr mutated non-small cell lung cancer treated with tyrosine kinase inhibitors (tkis) is one of the main challenges for targeted cancer therapy. Designing specific protac compounds to degrade egfr mutated proteins is expected to offer a promising approach to treating such patients and overcome drug resistance. - PEGSK (Additional S&H Or Hazmat Fees May Apply)
| SKU | PEGSK-64EGFRD19PEH |
|---|---|
| Supplier Part Number | 64EGFRD19PEH |
| UM | KT |
| UNSPSC | 41122102 |
| Manufacturer | Revvity |
| CountryOfOrigin | FR |
| ProductLine | PEGSK |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.00 |
| Lead Time | 4 Business Days |
| Hazardous | N |